Stryker enters into license, development, distribution agreements with Conformis totaling up to $30M: 4 details

Laura Dyrda -   Print  |

Conformis and Stryker penned an agreement for technology development, licensing and distribution on Oct. 1.

Four things to know:

1. Conformis entered into a licensing agreement for its patient-specific joint replacement instrumentation technology with Stryker. Stryker paid $14 million upfront, and could make up to $16 million in additional payments upon achieving certain milestones.

2. With this agreement, the companies will collaborate to design, manufacture and commercialize patient-specific instrumentation for use with Stryker's knee offerings, including the Triathlon total knee system.

3. The two companies also entered into a distribution agreement for Conformis to provide Stryker with patient-specific instrumentation. Conformis retains all IP for patient-specific implants.

4. Conformis' proprietary technology uses a CT-based 3D model to create disposable instrumentation for joint replacement procedures.

Editors Note: This article was updated at 4:25 pm CST to reflect that Stryker entered into a licensing agreement for patient-specific instrumentation, not patient-specific implants. Conformis will retain all IP for patient-specific implants.

More articles on orthopedics:
NuVasive aims to grow in robotics with new application
Zimmer Biomet adds to leadership ranks
Brainlab unveils mobile intraoperative robot for spine surgery


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers